Background
The immune responses generated by vaccination, natural infection, or a combination of both (“hybrid immunity”) are central to protection against viral pathogens. Understanding the magnitude, quality, and durability of these responses in people with HIV (PWH) is critical for informing prevention strategies and guiding immunization policies for this population.
Methods
Antiretroviral (ART)-treated PWH were recruited at the Grady Ponce Center in Atlanta (n=36) in 2021. Biospecimens were collected at different time points: after infection, after vaccination, or at later time points, reflecting infection + vaccination. Plasma SARS-CoV-2 humoral responses were evaluated by MesoScale platform. Cellular immune responses in peripheral blood mononuclear cells (PBMCs) were evaluated for the expression of immune exhaustion markers, antiviral proteins, and SARS-CoV-2-specific responses by flow cytometry. Immune responses were normalized by the time post-antigen exposure. The intercept of 1161 features were used to identify specific signatures induced by vaccination, infection and hybrid immunity.
Results
SARS-CoV-2 infection markedly enhanced inflammasome activity, with T, B, and innate cells showing increased ASC formation, NLRP3 expression, and active Caspase-1, alongside reduced NLRX1 and IFIT16, negative regulators of inflammasome signaling. Vaccination strengthened adaptive immunity through transcriptional programs supporting effector and memory T cell function, marked by increased ID2, T-bet, and TOX expression, and accompanied by a significant increase in SARS-CoV-2–specific CD4⁺ T cell (IFNγ⁺TNFα⁺) responses after in vitro peptide stimulation. Hybrid immunization, where infection primed innate responses and vaccination reinforced adaptive immunity, elicited superior outcomes across both arms. This included sustained elevations of plasma IFN-γ and IL-15, enhanced innate and T cell effector functions, and robust long-term memory (CD4 TCM/TSCM and CD8 TCM/TEM). Moreover, hybrid immunity generated significantly higher antibody titers against SARS-CoV-2 Spike and RBD compared with infection or vaccination alone.
Conclusions
Infection-driven innate imprinting may augment vaccine-induced adaptive programs, supporting stronger effector and memory responses and potentially more durable protection against SARS-CoV-2 observed during hybrid immunity, underscoring the clinical importance of vaccination even in previously infected individuals to maximize protective immunity.